BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32945898)

  • 41. Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.
    Perreault L; Newsom SA; Strauss A; Kerege A; Kahn DE; Harrison KA; Snell-Bergeon JK; Nemkov T; D'Alessandro A; Jackman MR; MacLean PS; Bergman BC
    JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.
    Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Taskinen MR
    Acta Diabetol; 1994 Apr; 31(1):6-13. PubMed ID: 8043900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.
    Piatti PM; Monti LD; Davis SN; Conti M; Brown MD; Pozza G; Alberti KG
    Diabetologia; 1996 Jan; 39(1):103-12. PubMed ID: 8720610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma free fatty acids and serum insulin in subjects feeding at 12-hour intervals; effects of methionyl growth hormone and of acipimox, an inhibitor of lipolysis.
    Pontiroli AE; Lanzi R; Monzani M; Musatti L; Guglielmone C; Pozza G
    J Endocrinol Invest; 1992 Feb; 15(2):85-91. PubMed ID: 1569294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of forearm immobilization and acipimox administration on muscle amino acid metabolism and insulin sensitivity in healthy, young volunteers.
    Dirks ML; Jameson TSO; Andrews RC; Dunlop MV; Abdelrahman DR; Murton AJ; Wall BT; Stephens FB
    Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E277-E289. PubMed ID: 38231001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.
    Halldin MU; Brismar K; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):735-43. PubMed ID: 12460323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients.
    Vestergaard ET; Hjelholt AJ; Kuhre RE; Møller N; Larraufie P; Gribble FM; Reimann F; Jessen N; Holst JJ; Jørgensen JOL
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2581-2592. PubMed ID: 30726969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling.
    Vestergaard ET; Gormsen LC; Jessen N; Lund S; Hansen TK; Moller N; Jorgensen JO
    Diabetes; 2008 Dec; 57(12):3205-10. PubMed ID: 18776138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucose flux is normalized by compensatory hyperinsulinaemia in growth hormone-induced insulin resistance in healthy subjects, while skeletal muscle protein synthesis remains unchanged.
    Nygren J; Thorell A; Brismar K; Essén P; Wernerman J; McNurlan MA; Garlick PJ; Ljungqvist O
    Clin Sci (Lond); 2002 Apr; 102(4):457-64. PubMed ID: 11914108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans.
    Badin PM; Louche K; Mairal A; Liebisch G; Schmitz G; Rustan AC; Smith SR; Langin D; Moro C
    Diabetes; 2011 Jun; 60(6):1734-42. PubMed ID: 21498783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.
    Nørrelund H; Nair KS; Nielsen S; Frystyk J; Ivarsen P; Jørgensen JO; Christiansen JS; Møller N
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4371-8. PubMed ID: 12970312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle.
    Hussey SE; Lum H; Alvarez A; Cipriani Y; Garduño-Garcia J; Anaya L; Dube J; Musi N
    Diabetologia; 2014 Mar; 57(3):582-91. PubMed ID: 24337154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute effects of ghrelin administration on glucose and lipid metabolism.
    Vestergaard ET; Djurhuus CB; Gjedsted J; Nielsen S; Møller N; Holst JJ; Jørgensen JO; Schmitz O
    J Clin Endocrinol Metab; 2008 Feb; 93(2):438-44. PubMed ID: 18042651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade.
    Gautier JF; Pirnay F; Jandrain B; Lacroix M; Mosora F; Scheen AJ; Cathelineau G; Lefèbvre PJ
    Eur J Appl Physiol Occup Physiol; 1994; 68(5):406-12. PubMed ID: 8076620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients.
    Alvarez P; Isidro L; Peinó R; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):431-6. PubMed ID: 14510904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
    Bramnert M; Segerlantz M; Laurila E; Daugaard JR; Manhem P; Groop L
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients.
    van Loon LJ; Manders RJ; Koopman R; Kaastra B; Stegen JH; Gijsen AP; Saris WH; Keizer HA
    Diabetologia; 2005 Oct; 48(10):2097-107. PubMed ID: 16096823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The control on growth hormone release by free fatty acids is maintained in acromegaly.
    Lanzi R; Losa M; Mignogna G; Caumo A; Pontiroli AE
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1234-8. PubMed ID: 10199760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.